Elsevier

Brain Research

Volume 590, Issues 1–2, 11 September 1992, Pages 229-238
Brain Research

Research report
Further evidence for differential affinity states of the serotonin1A receptor in rat hippocampus

https://doi.org/10.1016/0006-8993(92)91100-SGet rights and content

Abstract

The binding profile of [3H]8-hydroxy-2-(di-N-propylamino)-tetralin ([3H]8-OH-DPAT) to serotonin1A (5-HT1A) sites in rat hippocampal, frontocortical and striatal membranes has been compared. In these regions, [3H]8-OH-DPAT labels both a high and a low-affinity binding sites; the affinity values for each of the two sites are comparable in the different brain regions, but have different maximal capacity. By modifying the experimental conditions in a series of hippocampal membrane preparations, reciprocal changes in the proportion of the two sites were observed suggesting that they represent, at least in this region, different conformations or affinity states of a single receptor protein. In contrast to the lower affinity states, it appears that the high-affinity state is stabilized by coupling with a G-protein. Evidence supporting this statement is provided by addition of the guanine nucleotide Gpp(NH)p, breakage of labile disulfide bonds using N-ethylmaleimide and increasing membrane rigidity with ascorbate-induced lipid peroxidation, conditions which all reduced the density of receptors in the high-affinity state. Moreover, the high-affinity state appears to be stabilized at the expense of the lower affinity state in the presence of Mn2+. On the other hand, a complete shift to the low-affinity binding state was observed after a 24 h in vivo treatment with inhibitors of monoamine oxidase A (phenelzine or clorgyline) but not of monamine oxidase B (deprenyl). This disappearance of the high-affinity state with a concomitant increase in the binding capacity of the low-affinity state was reproduced by inhibiting monoamine oxidase A in vitro, as well as by reducing preincubation washout periods. Also, competitors of the [3H]8-OH-DPAT binding site, such as serotonin and unlabelled 8-OH-DPAT, display two affinity states while others like (±)-propranolol, tryptamine and spiperone recognize a single affinity component. These results suggest that the 5-HT1A binding site may exhibit at least two different affinity states depending upon its microenvironment and the intrinsic activity of the ligand used.

References (39)

  • D.N. Middlemiss et al.

    8-Hydroxy-2(di-n-propylamino) tetralin discriminates between subtypes of the 5-HT1 recognition site

    Eur. J. Pharmacol.

    (1983)
  • S.J. Peroutka

    5-Hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization

    Trends Neurosci.

    (1988)
  • J.F. Riordan et al.

    Reactions with N-ethylmaleimide and p-mercuribenzoate

    Methods Enzymol.

    (1972)
  • H. Schoemaker et al.

    [3H]8-OH-DPAT labels the serotonin transporter in the rat striatum

    Eur. J. Pharmacol.

    (1986)
  • A.J. Sleight et al.

    Chronic MAO A and MAO B inhibition decreases the 5-HT1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase

    Eur. J. Pharmacol.

    (1988)
  • S. Weiss et al.

    Serotonin 5-HT1 receptors mediate inhibition of cyclic AMP production in neurons

    Eur. J. Pharmacol.

    (1986)
  • B.S. Alexander et al.

    [3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum

    J. Pharm. Pharmacol.

    (1988)
  • A.C. Andorn et al.

    Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: Guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites

    Mol. Pharmacol.

    (1987)
  • D. Cooney et al.

    Receptor modification and receptor disposition in membranes

  • Cited by (71)

    • Translating biased agonists from molecules to medications: Serotonin 5-HT<inf>1A</inf> receptor functional selectivity for CNS disorders

      2022, Pharmacology and Therapeutics
      Citation Excerpt :

      Alternatively, binding of agonist compounds to the receptor may itself induce GPCRs to couple to their interacting G proteins (Laruelle, 2000; Skinbjerg et al., 2010). As concerns 5-HT1A receptors, the above comments are important in the study of novel agonist ligands because these may differentially label the receptors depending on their G-protein coupling state (see Table 2), thus generating affinity states which may differ between the biased agonists (Aznavour et al., 2006; Emerit, el Mestikawy, Gozlan, Rouot, & Hamon, 1990; Mongeau et al., 1992; Razakarivony, Newman-Tancredi, & Zimmer, 2021; Zimmer, 2016). PET studies with radiolabeled biased agonists can therefore be informative for investigating which brain regions are targeted and the coupling state of the receptors therein.

    • Serotonin receptor imaging by <sup>18</sup>F-PET

      2018, Fluorine in Life Sciences: Pharmaceuticals, Medicinal Diagnostics, and Agrochemicals Progress in Fluorine Science Series
    • Agonist and antagonist bind differently to 5-HT<inf>1A</inf> receptors during Alzheimer's disease: A post-mortem study with PET radiopharmaceuticals

      2016, Neuropharmacology
      Citation Excerpt :

      An improved understanding of the functional role of 5-HT1A receptors in AD may be gained by taking into account additional aspects of their pharmacological profile. Indeed, as G-protein-coupled receptors (GPCR), they have been shown to exist in different states (Mongeau et al., 1992; Nenonene et al., 1994): a high-affinity state for agonists, (effective receptor/G-protein coupling, supposedly active), and a low affinity (G-protein uncoupled, non-functional). Contrary to an agonist, an antagonist, like [18F]MPPF used in previous PET studies, indiscriminately labels all 5-HT1A receptors, regardless of their G-protein coupling state (Gozlan et al., 1995; Burnet et al., 1997).

    • Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT<inf>1A/2A</inf> receptor function

      2014, Neurochemistry International
      Citation Excerpt :

      In Fig. 3, we estimated levels of 5-HT1A receptor by [3H]8-OH-DPAT binding. However, [3H]-8-OH-DPAT is not without limitations, since it binds with high affinity only to those 5-HT1A receptors which are G protein-coupled (Emerit et al., 1990; Hall et al., 1985; Mongeau et al., 1992; Nenonene et al., 1994). Moreover, the ligand binding does not completely discriminate between surface and intracellular receptors.

    View all citing articles on Scopus
    View full text